Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Florida Weight Loss MD vs NexLife

Florida Weight Loss MD
Graded #333

Lower grade

vs+8.700000000000003
NexLife
Graded #147

Higher grade

The verdict

NexLife takes it — 68.5/100 to 59.8/100.

NexLife grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. NexLife is a LegitScript-certified telehealth platform offering compounded semaglutide (from $145/mo) and compounded tirzepatide (from $186/mo).

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueNexLife +20
50
70
Dose & formulationNexLife +11
53
64
Clinical oversightNexLife +11
78
89
Labs & monitoringFlorida Weight Loss MD +9
62
53
FulfillmentEven
67
67
Contract termsNexLife +8
47
55
Florida Weight Loss MD · left barNexLife · right bar

The numbers

MetricFlorida Weight Loss MDNexLife
WeighScore59.8/10068.5/100
GradeCC
Scorecard rank#333#147
SemaglutideNot disclosed$165/mo (compounded)
TirzepatideNot disclosed$215/mo (compounded)
Coverage1 statesCoverage not published
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyInjection only
Florida Weight Loss MD

Graded #333 · C

Strengths

  • Physician-led (Dr. Sergey Terushkin, MD, FACS) with same-day telehealth visits statewide in Florida
  • Offers both compounded GLP-1 and brand Wegovy/Ozempic/Mounjaro/Zepbound when appropriate
  • Accepts most insurance or self-pay; consult $99 with $49 applied to the program

Where it loses points

  • Florida residents only — no service outside the state
  • Monthly medication pricing is not published; disclosed after evaluation
  • Single-clinic operation rather than a national telehealth platform
NexLife

Graded #147 · C

Strengths

  • LegitScript certified platform
  • Works exclusively with LegitScript-certified, NABP-accredited pharmacies — strongest pharmacy trust signal in the dataset
  • Both semaglutide and tirzepatide at competitive pricing
  • Semaglutide from $145/mo on the 12-month plan ($165/mo month-to-month) - among the lowest in the dataset

Where it loses points

  • State availability not publicly disclosed
  • Compounded only — no brand-name options
  • Also covers hormone optimization and longevity
  • Lowest advertised rates ($145 sema / $186 tirz) require a 12-month plan commitment

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard